Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP)

NCT: NCT06463418 · ACTIVE_NOT_RECRUITING

NCT IDNCT06463418
StatusACTIVE_NOT_RECRUITING
Start Date2024-12-20
Completion2026-11-30

Brief Summary

The goal of this feasibility trial is to learn if exoskeleton or robotic walking works to reduce nerve (neuropathic) pain after spinal cord injury. This study asks is: * Providing walking practice through use of a robotic device (exoskeleton) three times per week for twelve weeks possible to deliver? * Would people sign up and stick to the programme? * And will it help to reduce neuropathic pain levels after spinal injury? Researchers will compare robotic walking and a relaxation program to see if robotic walking works to reduce neuropathic pain levels after spinal injury. Participants will: * Complete a number of questionnaires and tests related to their pain before the trial. * Complete robotic walking or a relaxation program three times per week for twelve weeks. * Complete the same questionnaires and tests after the trial finishes and 6 months after. * Complete an interview telling researchers about their experiences of the trial.

Frequently Asked Questions

What is Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP)?

Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP) is a clinical trial registered under NCT06463418. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06463418?

The current status of NCT06463418 (Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP)) is: ACTIVE_NOT_RECRUITING.

When did Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP) start?

Exoskeleton Training for Spinal Cord Injury Neuropathic Pain (ExSCIP) started on 2024-12-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.